Wolverine Trading’s ChemoCentryx, Inc. CCXI Stock Holding History

Wolverine Trading’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-28,300	Closed	-$708K	–	6166
2022 Q1	$708K	Buy	+28,300	New	+$795K	﹤0.01%	2829
2021 Q4	–	Sell	-50,100	Closed	-$980K	–	7275
2021 Q3	$980K	Sell	50,100 -27,900	-36%	-$435K	﹤0.01%	3014
2021 Q2	$1.1M	Buy	+78,000	New	+$1.92M	﹤0.01%	2669

Other funds holding CCXI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

SFM

Soros Fund Management New York $9.12B AUM 30.69% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Wolverine Trading's CCXI Position: Q3 2022 in Review

Wolverine Trading sold out of ChemoCentryx, Inc. (CCXI) in Q3 2022, closing a stake of 10,548 shares — an estimated $269K sold.

Wolverine Trading first reported a position in CCXI in Q2 2021 and held it in 3 quarters. The position peaked at $897K in Q2 2021. 217 funds tracked by Wall St. Rank hold CCXI as of Q3 2022.

Wolverine Trading reported no remaining ChemoCentryx, Inc. position as of Q3 2022 after selling out during the quarter.
Wolverine Trading sold 10,548 ChemoCentryx, Inc. shares in Q3 2022, an estimated $269K.
Wolverine Trading first reported a position in ChemoCentryx, Inc. in Q2 2021 and held it in 3 quarters.
Wolverine Trading's ChemoCentryx, Inc. position peaked at $897K in Q2 2021.
217 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q3 2022.

Based on Wolverine Trading's 13F filing for Q3 2022, filed 14 Nov 2022.